Not to mention that biotech in general is way down. Then move to speculative, pre-revenue biotechs and those are down even more. It’s not like any company similarly positioned as CYDY is having a banner year. They’re all getting crushed. Acting like the drop to where we’re currently at is just because of bad management is ridiculous.